Open Access

Metabolism under hypoxia in Tm1 murine melanoma cells is affected by the presence of galectin-3, a metabolomics approach

  • Pedro Starzynski Bacchi1,
  • Antonio Carlos Bloise2,
  • Silvina Odete Bustos1,
  • Lara Zimmermann1,
  • Roger Chammas1Email author and
  • Said Rahnamaye Rabbani2Email author
SpringerPlus20143:470

https://doi.org/10.1186/2193-1801-3-470

Received: 26 June 2014

Accepted: 13 August 2014

Published: 26 August 2014

Abstract

Metabolomics has proven an useful tool for systems biology. Here we have used a metabolomics approach to identify conditions in which de novo expression of an established tumor marker, galectin-3, would confer a potential selective advantage for melanoma growth and survival. A murine melanoma cell line (Tm1) that lacks galectin-3 was modified to express it or not (Tm1.G2 and Tm1.N3, respectively). These variant cell line were then exposed to conditions of controlled oxygen tensions and glucose levels. Metabolic profiling of intracellular metabolites of cells exposed to these conditions was obtained in steady state using high resolution 1H Magnetic Resonance Spectroscopy (1H-MRS) and multivariate statistical analysis. The Nuclear Magnetic Resonance (NMR) spectra contained a large number of absorption lines from which we were able to distinguish 20 metabolites, 3 fatty acids and some absorption lines and clusters were not identified. Principal Components Analysis (PCA) allowed for the discrimination of 2 experimental conditions in which expression of the tumor marker galectin-3 may play a significant role, namely exposure of cells to hypoxia under high glucose. Interestingly, under all other experimental conditions tested, the cellular system was quite robust. Our results suggest that the Metabolomics approach can be used to access information about changes in many metabolic pathways induced in tumorigenic cells and to allow the evaluation of their behavior in controlled environmental conditions or selective pressures.

Keywords

Metabolomics Galectin-3Melanoma1H-MRSNMRPCAWarburg effect Tm1.G2 Tm1.N3

Background

Melanomas are tumors derived from melanocytes, the pigment-producing cells of the skin (Velho, 2012). Cells that undergo the carcinogenic process, i.e. transform into tumor cells, present intracellular changes, such as immortalization, independence of growth signals and metabolic changes that significantly modify the intracellular and the tumor microenvironment (Hanahan and Weinberg, 2011). One of these changes was first described by Otto Warburg, who observed modifications in the metabolism of intracellular glucose. Warburg observed a curious effect, named after him, in which the tumor cells were characteristically glycolytic even at normal oxygen concentrations. The Warburg effect appears disadvantageous because glycolysis generates 9 times less ATP than oxidative phosphorylation, in addition, the production of lactate generates an exacerbated acidosis in the tumor microenvironment that is harmful to normal cells; furthermore, cells begin to import larger amount of glucose that can be diverted for PPP (pentosephosphate) pathway, which produces NADPH and ribose-5-phosphate (Heiden et al. 2009).

Apparently the Warburg effect makes the transformed cell more resistant. Since intratumoral blood flow is very heterogeneous and oxygen concentrations vary widely, cells that depend on oxidative phosphorylation are impaired within tumors. The occurrence of the Warburg effect is associated with activation of oncogenes such as Akt and Myc and has a close connection with the hypoxia-induced factor (HIF-1), which is involved in the induction of glycolysis (Gatenby and Gillies, 2004; Heiden et al. 2009).

A model of murine melanoma progression was derived from a murine melanocyte cell line (Melan a) through repeated cycles of cell deadhesion (Oba-Shinjo et al. 2006). This model included several cell lines, such as Tm5 and Tm1, the latter used in the present work. Previous studies indicated that these cell lines had a down regulation of proteins involved in ROS degradation and were more pro-oxidative than the parental cell line, Melan a, and survived in conditions of oxidative stress (de Souza et al. 2006). Transcriptomic analysis of malignant transformation indicated that one of the major differences between Tm1 cells and the parental cell line was the loss of expression of gal-3 in the tumorigenic cell line, Tm1 (de Souza et al. 2006).

Galectin-3 is a multifunctional protein member of the group of lectins that bind to β-galactosides. Gal-3 is involved in different biological processes and these functions are dependent of its subcellular localization. In the extracellular space the biological activities of gal-3 involve interactions with galactosides, useful to mediate cell-cell adhesion and modulate negatively the cell adhesion to ECM proteins (Nangia-Makker et al. 2008). Gal-3 can also cross-link glycoconjugates present on the cell surface in order to activate several signaling pathways associated with cell death and apoptosis (Newlaczyl and Yu, 2011). Gal-3 is capable to bind various molecules in the cells; which could explain its contrasting functions. In the intracellular environment, gal-3 is involved in differentiation, regulation of cell proliferation through interactions with K-Ras (Levy et al. 2010) or with phosphatidylinositide 3-kinases (PI3K-Akt), and cell survival. In the cytoplasm, galectin-3 inhibits cytochrome c release from mitochondria, thus preventing caspase-3 activation, possibly through an interaction with the anti-apoptotic protein bcl-2. Also, gal-3 is enriched in mitochondria and it seems to regulate the mitochondrial homeostasis, acting as an apoptotic inhibitor (Matarrese et al. 2000). Gal-3 interacts physically with the mitochondrial ATP synthase among other proteins (Carvalho et al. 2014) and decrease mitochondrial ATP production in cancer cells (Kim et al. 2008). Inside the nucleus, gal-3 promotes the pre-mRNA splicing and can enhance or stabilize transcription factors. Furthermore, gal-3 has an important role in transduction of Wnt/beta-catenin pathway, related with development, tissue homeostasis and tumor growth. In addition, gal-3 directly activates AP-1, a transcription factor that transcribes metalloproteinases such as MMP-1, involved in invasion (Dye et al. 2013).

Melanocytes residing in the basal layer of the epidermis are in relatively hypoxic microenvironment. It is documented that melanoma development and aggressiveness can be modulated by various tumor microenvironmental factors including underoxygenation of the tumor mass (Bedogni and Powell, 2009). At the same time, gal-3 expression is responsive to hypoxia and seems to be regulated by HIF-1α (Zeng et al. 2007). In order to establish the possible role of gal-3 in murine melanomas, we had then transfected Tm1 cells with either an empty vector (Tm1.N3) or a vector coding gal-3 gene (Tm1.G2). Thus, a controlled cellular system was generated to determining the impact of gal-3 expression in mitochondrial metabolism of tumorigenic cells and a metabolomics approach was used to map quantitatively the intermediates of glucose metabolism by measuring their concentrations in distinct cell lines at varying concentrations of oxygen and glucose.

The Metabolomics approach results from spectroscopy methods such as Raman, Infra-Red (FT-IR), mass spectrometry (liquid and gas) and 1H MRS combined with multivariate statistical analysis (Griffin, 2004). This method, for example, can be applied as diagnostic tool to study changes in metabolic pathways induced by a certain pathological situation such as melanomas (Triba et al. 2010) or mdx, animal model for Duchenne Muscular Dystrophy (Martins-Bach et al. 2012). In this work high resolution NMR spectra were used to study the changes in concentration levels of each metabolite and through multivariate statistical analysis (Principal Component Analysis – PCA), patterns were identified and associated with varying conditions of tumor cell exposure. A fingerprint was then obtained from either galectin-3 positive or negative cells under different metabolic conditions.

Materials and methods

Cell culture

Murine cells were cultured in RPMI-1640 medium, pH adjusted to 7.2 and supplemented with 5% of a mixture consisting of fetal bovine serum as a supplement to stimulate cell division. From the tumorigenic cell line Tm1, two new variants were obtained by cell transfection procedures in order to obtain Tm1.G2 (cells that restart to express gal-3 due to a specific transfection) and Tm1.N3 (cells that remain not expressing the gal-3 after the transfection was done by a plasmid; also called control transfection) (Figure 1). G418 antibiotic was added in the cultures of transfected cells. To detach cells, the entire medium was aspirated through a Pasteur pipette attached to the vacuum pump. The cells were washed twice with PBS/EDTA; trypsin was finally added and its activity inhibited thereafter by addition of supplemented medium. Tm1.G2 and Tm1.N3 were submitted to two different conditions of oxygen tension (hypoxia, 1% oxygen gas concentration and normoxia with 20% of oxygen concentration) and glucose levels (high 25.0 mM and control 11.1 mM). Previous analyses showed that exposure of cells to hypoxia, as defined above, did not alter gal-3 expression in the cell variants studied herein (Figure 1). Approximately, 1 × 107 cells were counted for each cell line using trypan blue staining (for exclusion of non-viable cells) in a Neubauer chamber viewed with light microscopy. Hypoxia condition was achieved by using an appropriate chamber (Modular Incubator Chamber, Billups-Rothenberg) filled with 95% of nitrogen and 5% of carbon dioxide. After 10 minutes of gases exchange, the chamber was sealed and placed in a humidified atmosphere at 37°C for 24 hours and oxygen concentration monitored by an oxymeter (Dräger – PAC 3000).
Figure 1

Galectin-3 accumulation did not alter upon exposure of cells to hypoxic conditions. The normal murine melanocyte cell line, Melan-a, gave rise to the melanoma cell line Tm1, as described elsewhere (Oba-Shinjo et al. 2006). Lack of galectin-3 expression was among the differences between the tumor cell lines and their normal counterpart (de Souza et al. 2006). We had then transfected the galectin-3 gene in the tumorigenic cell line Tm1, obtaining clones such as the ones used in this study. Control transfectants were obtained by transfection of the empty plasmid pEF1.neo (Tm1.Neo cells, Tm1.Nx cells) and the galectin-3 expressing cell was obtained by transfection of the galectin-3 coding plasmid pEF1.neo/gal3 (Tm1.Gal-3, Tm1.Gx cells). Protein extracts of the cell lines studied were routinely analyzed by western blots. Loading controls were done analyzing β-actin accumulation and galectin-3 expression was analyzed with specific monoclonal antibodies (M3/38, rat anti-galectin-3). Exposure of cells to hypoxia (atmospheres containing 1% oxygen) for 24 hours did not interfere with accumulation of galectin-3, differently from the exposure of cells to cobaltous chloride, a prolyl-hydroxylase inhibitor (and so-called “hypoxic mimetic” drug). Western blots were done after resolving protein extracts in 10% SDS-polyacrylamide gels. Plus and minus signs represent whether cells were exposed or not to a given experimental condition.

NMR sample preparation

Cells collected upon 90% confluency and > 95% viable, as indicated by trypan blue exclusion staining were separated for NMR analysis. Cells were homogenized in 250 μL of methanol/water (1:1) solution at 4°C (Wu et al. 2008), sonicated 5 times for a period of 1 minute with intervals of 10 seconds between rounds of sonication. The reagents and cells were mixed with a rapid manual shaking and centrifuged at 13000 g for 20 minutes. Finally, supernatant (methanol, water and metabolites) was collected and lyophilized. The lyophilized extracts were diluted in 600 μL of deuterium oxide (D2O, Sigma-Aldrich) and transferred into 5 mm resonance tubes. Capillaries containing ~ 2 μL a solution of D2O and 0.75% 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid, sodium salt (TSP, Sigma-Aldrich) were inserted in the tubes to be used as NMR reference. Tubes were then stored at 4°C until the beginning of resonance experiments. The combination of the 3 preparation conditions mentioned before as cell transfection (G2 and N3), oxygen tension (hypoxia and normoxia) and glucose levels (high and control) resulted in 8 combinations (groups). Besides, each combination also contained 3 independent samples (triplicate) in order to aggregate statistical value to the results, which results in 24 samples analyzed by NMR.

NMR spectroscopy

High resolution 1H NMR spectra were acquired in a Varian spectrometer (Varian Associated, Inc., Palo Alto, CA, USA) operating at 9.4 T, corresponding to 400 MHz for protons, using a 5 mm multinuclear probe with 3 channels: decoupling, observe and deuterium lock. Spectra were acquired at 21°C using the single pulse sequence with following parameters: relaxation delay 6.0 s, excitation pulse width 3.7 μs, acquisition time 4.1 s, spectral window 4.0 kHz, 32Kb data points and 1024 transients (approximately, 3 hours per experiment). Selective saturation of residual water was carried out using pulse width of 1.5 s at water position. A weighted Fourier transform with an exponential function corresponding to 0.3 Hz line broadening was applied to the spectra followed by phase and baseline correction. The region from 4.50 to 5.50 ppm of spectra, overlapping the water absorption, was not considered in analysis and the vertical scale was normalized by the TSP area integrated over -0.008 to 0.008 ppm range. Subsequently, the spectra were also normalized by its total area integrated over 0.45 to 4.50 ppm range (aliphatic hydrogens).

Statistics and pattern recognition processing of data

The normalized absorption line/lines corresponding to different metabolite were integrated over the extension of the peak/peaks and each integral was used as one input to the multivariate matrix. In general, the metabolite identification was done using Chenomx (Chenomx NMR Suite, Chenomx Inc.) (Chenomx, 2011). However, some of this regions (or peaks) could not be appropriately identified by Chenomx and therefore other data base were used, such as, BMRB - Biological Magnetic Resonance Bank (Ulrich et al. 2008) and some references (Jansen et al. 2006; Romanska et al. 2009; Shi et al. 2008; Triba et al. 2010). The total area under the spectra was calculated taking in to account the entire spectra (0.45 – 4.5 ppm), while the area of each absorption line was calculated taking in to account only the extension of each line or interval of lines. Therefore, the total sum of the areas from absorption lines is slightly smaller than the total area under the spectra. To make these two areas equal, we had to add an extra absorption line, P, with the area equal to total area minus the sum of the areas of the absorption lines.

In order to obtain the relative concentration of the metabolites the average normalized area of each peak per triplicate was calculated and arranged in a multivariate matrix (8 × 30), 8 groups and 30 peaks, used in statistical analysis. The multivariate statistical methods chosen in this work was PCA (SIMCA-P + 11; Umetrics) (Umetrics, 2007) using auto-scaled analysis, where all input variables’ variances were re-normalized to unit variance. This normalization provides a reliable identification of variation in metabolites with low concentration that normally would not be detectable by naked eyes (Griffin et al. 2001a; Griffin et al. 2001b). When clusters of points were observed in the score plots, loading plots were analyzed to identify the metabolites which are responsible for the clustering of similar samples. In parallel to the multivariate analysis, the differential metabolites pointed by PCA were validated at a univariate level using ANOVA and Fisher’s test. The critical α-value used as threshold in this study was set to 0.05.

Results

In order to understand the impact of gal-3 expression in mitochondrial metabolism, spectra of 24 samples, divided in 8 groups, were obtained. Each group contained 3 sets of samples with identical nominal transfection, oxygen tension and subjected to same concentration of glucose. Each sample was specified by three letters: the first letter indicates the cell line, “G” for Tm1.G2 and “N” for Tm1.N3, the second letter indicates the oxygen tension, “h” for hypoxia and “n” for normoxia and, finally, the third letter indicates the glucose concentration used in cultures, “h” for high and “c” for control.

Figure 2 shows a typical melanoma (Tm1.G2 hypoxia and high glucose, Ghh) 1H-MRS spectrum, each one contains a large number of absorption lines from which we were able to distinguish 20 metabolites, 3 fatty acids located at 0.740, ≈ 0.9 and 1.534 ppm, 6 unidentified absorption lines and few other lines, which were not considered, due to their small intensity compared to other absorption lines. As it can be seen in Table 1, the absorption lines corresponding to these 20 metabolites can have a singlet, doublet, triplet, quartet or multiplet structures. For example, lactate is composed by a doublet at 1.329 and 1.346 ppm and a quartet at 4.082 – 4.153 ppm interval. Furthermore, there is an interval (4.180 – 4.470 ppm), which corresponds to the overlap of absorption lines of AMP, ADP, ATP, GDP, NADP+ and a single line at 2.134 ppm, which could correspond to different metabolites, see Table 1.
Figure 2

Typical 1 H high resolution spectrum, obtained at 400 MHz and 21°C, from melanoma cells ( Tm1.G2 hypoxia and high glucose) showing only the chemical shift range corresponding to aliphatic hydrogen (4.5 – 0.45 ppm). The absorption lines due to 3-hydroxyisovalerate (P5), lactate (P6), alanine (P7), acetate (P9), acetone (P11), methylamine (P14), dimethylamine (P16), trimethylamine (P18), creatine (P19) and free choline (P22) are depicted with arrows.

Table 1

Assignments of resonance peaks obtained from 1 H-MRS data

 

Peaks

Metabolites

1

0.740

Cholesterol C-18 methyl singlet

2

≈0.900

fatty acid chains ω-CH3

3

1.115

Unidentified

4

(1.176,1.192)

3-hydroxybutyrate

5

1.260

3-hydroxyisovalerate

6

(1.329,1.346) and (4.082 – 4.153)

Lactate

7

(1.477,1.495) and (3.740 – 3.796)

Alanine

8

1.584

fatty acid β-methylene (CH2CH2COO)

9

1.924

Acetate

10

2.134

Unidentified (methionine, acetylcholine, glutamate, homocysteine)

11

2.240

Acetone

12

(2.343,2.363,2.381)

Glutamate

13

2.413

Succinate

14

2.572 and 2.736

Citrate range

15

(2.594 – 2.637)

Unidentified (distribution of singlet lines)

16

2.713

Dimethylamine (most probable)

18

2.883

Trimethylamine

19

3.044 and 3.938

Creatine

20

3.079

Unidentified

21

(3.120,3.147)

Malonate range

22

3.188

Free choline

23

3.228 and 3.241

PC/GPC

24

(3.243 – 3.290) and (3.400 – 3.455)

Taurine

25

3.390

Unidentified

26

3.562

Glycine

27

3.705

Unidentified (broad line at ~3.70 ppm)

28

3.956

Creatine phosphate (most probable)

29

(4.180 – 4.470)

Unidentified (AMP, ADP, ATP, GDP, NADP+)

30

-

P

The integral of different parts of the spectra corresponding to 20 metabolites, 3 fatty acids and 6 unidentified compounds plus P (extra absorption line), see Table 1, were used to build the multivariate matrixes of (24 × 30) corresponding to 24 samples per 30 integration intervals or in averaging the triplicate of each group the matrix was reduced to a (8 × 30). PC analysis for both matrixes, (24 × 30) and (8 × 30) were performed, Figures 3 and 4 show the results for the reduced matrix, which is almost the same as for the (24 × 30) matrix. The areas were calculated based on trapezoids method in an automatic routine developed in our laboratory using Pascal language.
Figure 3

Principal components analysis ( score plot of PC1 vs. PC2) from different cell lines (first letter “ G ” and “ N ” means G2 and N3 , respectively) submitted in two different conditions of oxygen tension (second letter “ h ” and “ n ” means hypoxia and normoxia, respectively) and glucose levels (third letter “ h ” and “ c ” means high and control, respectively), corresponding to 8 mean values of each triplicate. To facilitate the visualization of results, the open symbols represent the G2 and solid represent N3 lines Key: Nhh, Ghh, ■ Nhc, □ Ghc, ▲ Nnh, ∆ Gnh, ♦ Nnc and Gnc.

Figure 4

Principal components analysis ( score plot of PC1 vs. PC3) from different cell lines (first letter “ G ” and “ N ” means G2 and N3 , respectively) submitted in two different conditions of oxygen tension (second letter “ h ” and “ n ” means hypoxia and normoxia, respectively) and glucose levels (third letter “ h ” and “ c ” means high and control, respectively), corresponding to 8 mean values of each triplicate. To facilitate the visualization of results, the open symbols represent the G2 and solid represent N3 lines. Key: Nhh, Ghh, ■ Nhc, □ Ghc, ▲ Nnh, ∆ Gnh, ♦ Nnc and Gnc.

The first three Principal Components are responsible for approximately 80% of total data variance for PCA. Besides, confidence level on parameters is 95% in PC analysis. To ensure statistical significance for PCA results, ANOVA and Fisher’s test were used to treat each metabolite pointed in multivariate results in order to retain only those comparisons with significance level, α, of 5%. Table 2 resumes these results.
Table 2

Summary of results obtained from ANOVA and Fisher’s test

Metabolite

l.s.d.

|Nhh – Ghh|

|Nhh – Ghc|

|Ghh – Ghc|

Lactate

0.03048

0.04277

0.06494

0.02217

Free choline

0.00677

0.00345

0.00945

0.00600

PC/GPC

0.01748

0.00876

0.02713

0.01838

Citrate (P14)

0.01680

0.01035

0.01916

0.02950

P27

0.07465

0.11239

0.01375

0.12614

Creatine

0.01392

0.01980

0.03537

0.05517

Glutamate

0.00257

0.00300

0.00616

0.00916

Succinate

0.00077

0.00003

0.00198

0.00200

Taurine

0.00786

0.01243

0.01271

0.02514

Glycine

0.00324

0.00466

0.00605

0.01071

AMP, ADP, ATP, GDP, NADP+

0.01087

0.01098

0.01139

0.02237

Alanine

0.00461

0.00075

0.01343

0.01418

Parameters used were: α = 5% (significance level), N = 24 (total of elements in multivariate matrix), k = 8 (groups), n = 3 (elements by group) and Fisher’s coefficient of 2.12. Least significant difference (l.s.d.), |Nhh – Ghh|, |Nhh – Ghc| and |Ghh – Ghc| were calculated. These differences were considered statistically significant only when they were greater than l.s.d.

Figures 3 and 4 show the plots of PC1 vs. PC2 and PC1 vs. PC3, which summarize the main results regarding the separation of groups (score plots) obtained from PCA. As it can be seem in both figures the separation between groups Ghh and Nhh are far away from each other which suggests that these two groups have different cellular metabolism.

As it can be seen in Figures 3 and 4G2 and N3 cell lines, when both are in hypoxia and higher glucose, are located in different quadrants. In this sense, the PCA results seem to suggest that additionally to the differences between G2 and N3 cell lines already mentioned, the oxygen tension and glucose levels are important conditions and somehow they amplify the differences between these cells and therefore should be carefully analyzed. On a biological perspective, galectin-3 may interfere in the metabolism of melanoma cells specifically under such conditions.

In order to discriminate the metabolites responsible for the separation observed in score plots of Figures 3 and 4, loading plots were analyzed. Table 3 shows the results obtained from the PC1 vs PC2 loading plot, representing the tendencies of increase and decrease of different metabolites in distinct set of samples. The statistical significance of the changes was tested in Table 2. For example, in third column of Table 3 the metabolites lactate, free choline and PC/GPC are increased in Nhh in comparison with Ghc.
Table 3

Summary of differences between groups pointed out by the upward arrows mean increases and downward arrows mean decrease

Assignments

Nhh compared to Ghh

Nhh compared to Ghc

Ghh compared to Ghc

Lactate

 

Free choline

 

 

PC/GPC

 

 

Citrate (P14)

  

P27

  

Creatine

 

Glutamate

 

Succinate

 

Taurine

Glycine

 

AMP, ADP, ATP, GDP, NADP+

 

Finally, the analysis of this metabolic chart with their tendencies of alterations in the samples may provide information regarding the cellular metabolism such as glycolytic pathway, Krebs cycle, mitochondrial regulation, glutaminolysis and PPP pathway.

Discussion

In this work Metabolomics analysis was used in two different cell lines, G2 (transfected Tm1 melanoma cells expressing gal-3) and N3 (transfected Tm1 melanoma cells not expressing gal-3), grown at certain conditions of oxygen tension (hypoxia and normoxia) and glucose levels (control or high concentration) in order to identify characteristic metabolic alterations related to gal-3 expression.

Among the results, two major distinctions regarding the metabolism of observed samples can be established. First, in the PCA charts, the “hh” samples are far apart from the rest, implying that hypoxia associated with high glucose levels can have great impacts on cell metabolism, which is rather intuitive. Second, the Ghh and the Nhh samples have presented wide metabolic differences, demonstrating the impact of gal-3 expression in the melanoma cell line.

As it can be seen, robustness in the bioenergetic system is maintained in most samples, which are grouped together, but it is violated in the “hh” condition. It follows that this medium may have profound effects in cell metabolism. It is worth of note that the glucose diffusion pattern is different from that of oxygen; pO2 declines more rapidly than monosaccharide levels with distance from capillaries (Gatenby and Gillies, 2004). Hence, these conditions may exist inside tumors, which are poorly vascularized.

Doubtless the Ghh-Nhh distinction is the richest data obtained. In hypoxia and high glucose conditions, the impact of gal-3 in bioenergetic reprogramming becomes evident, whatever its precise role may be. Lactate is remarkably increased in Nhh cells, probably indicating that under these conditions gal-3 deficient cells are more glycolytic than gal-3 expressing cells. However, this does not mean that an Nhh tumor will necessarily be more glycolytic than Ghh or Ghc once the microenvironment cells metabolism is also deregulated during carcinogenesis, a process called reverse Warburg effect (Bonuccelli et al. 2010). Free choline, GPC (glycerophosphocholine) and PC (phosphocholine) are also increased in Nhh, being these molecules normally associated with cell membrane biosynthesis (Jansen et al. 2006; Triba et al. 2010), so their concentrations generally reflect an enhanced cellular growth and proliferation typically observed in tumors. In this case, our results show that Nhh may be presenting intense cell proliferation rate when compared to Ghc. This observation supports the fact that in the intra-cellular environment, gal-3 gene is involved in regulation of cell proliferation, differentiation and survival through specific interactions with the oncogene K-Ras or with PI3K-Akt signaling pathway.

A behavior was observed for taurine level between two different comparisons among groups. For the case Nhh compared to Ghh, was observed a decrease of this metabolite for cell lines expressing galectin-3 whereas for Nhh compared to Ghc was observed an opposite tendency. It is known in literature (Hansen et al. 2006) that taurine is related to the oxidative metabolism which occurs in the mitochondria. Hansen et al. (Hansen et al. 2006) demonstrated that high concentration of this metabolite is found in tissues of high oxidative activity, while low concentration is observed in tissues with primarily glycolytic activity. The authors proposed that when the taurine is found inside the mitochondria, it acts to prevent leakage of the Reactive Oxidative Species (ROS) formed in the environment of these organelles, and hence acts as an anti-oxidant agent. Mitochondrial ROS can stabilize HIF, are important signaling molecules and mitogens (Wallace et al. 2010) and also can contribute to neoplastic transformation. It has been observed that in colon cancer cells gal-3 interacts with F0F1 ATPase, the mitochondrial powerhouse, and may influence cell cycle progression (Kim et al. 2008). These arguments suggest that cellular metabolism may be more pro-oxidative for cell lines which do not expressing gal-3 gene in hypoxia and high glucose when compared with those that do expressing in same grown conditions. However, when the same comparison between both cell lines is made changing high glucose to control for G2 lineage, we observed an interesting opposite tendency. This fact, even seeming ambiguous, suggests that only condition “hh” may be promoting mitochondrial homeostasis for those cell lines with expressing gal-3 gene.

All these gal-3 driven metabolic alterations may have profound impact in cell signaling and consequently in cell growth, division and differentiation. Mitochondrial metabolism changes have great influence in cell signaling, alteration of chromatin methylation and of the epigenome: they can reprogram the nucleus in a process called retrograde signaling (Wallace, 2012). Through specific interactions with HIF or with PI3K pathway, gal-3 can influence mitochondrial metabolism and hence trigger cancer-related responses.

Looking at Ghh-Nhh peak area comparisons, only few differences could be pointed. Instead, information concerning the metabolic shift emerges when the spectra areas were statistically analyzed and samples were grouped using PCA. Some metabolic differences between Ghh and Nhh were analyzed and illustrated in Figure 5. In addition to the normal metabolic pathways, the deviations observed in the experiment can be now seen in a contextualized manner.
Figure 5

Schematic overview of changes in cellular metabolism indicated in the two cell lines of melanoma submitted to “ hh ” condition. The arrows indicate metabolites which are increased in Nhh samples compared to Ghh.

Conclusions

Metabolomics was an exploratory and non-supervisioned approach through which cells’ metabolic steady states could be compared in presence and absence of gal-3 expression. Our results showed some changes in concentration of certain metabolites which may be attributed to the impact of galectin-3 in the mitochondrial homeostasis process. Among all metabolites pointed out by multivariate analysis, the most relevant to distinguish between cell lines that expressing gal-3 gene for those that do not expressing were lactate, free choline, GPC/PC, acetate, 3-hydroxybutyrate and taurine. We propose that the gal-3 seems to act in the mitochondrial homeostasis only in the specific case where tumorigenic cell are exposed to stress, such as hypoxia condition. A possible explanation for the homeostasis relies on the fact that cells expressing galectin-3 are able to remove from cellular environment those mitochondrias that do not properly metabolize pyruvate received from the glycolytic pathway (“deficient” mitochondria). As discussed, galectin-3 was proven to adapt the cell to a certain environmental pressure and the investigative focus shifted towards these conditions where the samples did not cluster in multivariate analysis. A great spectrum of possibilities emerges to elucidate gal-3 functionalities.

Declarations

Acknowledgements

The authors would like to acknowledge the FAPESP for partly funded this project (project number 1998/14247-6), IPT (CMQ/LAQ) for allowing us to use their NMR spectrometer and Martha G. Perez for running the NMR experiments and Claudia M. G. de Souza by her collaboration.

Authors’ Affiliations

(1)
Laboratório de Oncologia Experimental and Centro de Investigação Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo and Faculdade de Medicina da Universidade de São Paulo
(2)
Laboratório de Ressonância Magnética, Instituto de Física da Universidade de São Paulo

References

  1. Bedogni B, Powell MB: Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin. Pigment Cell Melanoma Res 2009, 22: 166-174. 10.1111/j.1755-148X.2009.00553.xView ArticleGoogle Scholar
  2. Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell R, Fatatis A, Witkiewicz A, Vander Heiden M, Migneco G, Chiavarina B, Frank P, Capozza F, Flomenberg N, Martinez-Outschoorn U, Sotgia F, Lisanti M: The reverse Warburg effect Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010, 9: 1960-1971. 10.4161/cc.9.10.11601View ArticleGoogle Scholar
  3. Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA: Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biol Ther 2014, 15: 840-850. 10.4161/cbt.28873View ArticleGoogle Scholar
  4. Chenomx: Chenomx NMR Suite 7.6. 2011.Google Scholar
  5. de Souza G, Godoy L, Teixeira V, Otake A, Sabino A, Rosa J, Dinarte A, Pinheiro D, Silva W, Eberlin M, Chammas R, Greene L: Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics 2006, 6: 1460-1470. 10.1002/pmic.200500243View ArticleGoogle Scholar
  6. Dye DE, Medic S, Ziman M, Coombe DR: Melanoma Biomolecules: Independently Identified but Functionally Intertwined. Front Oncol 2013, 3: 252.View ArticleGoogle Scholar
  7. Gatenby R, Gillies R: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004, 4: 891-899. 10.1038/nrc1478View ArticleGoogle Scholar
  8. Griffin J: Metabolic profiles to define the genome: can we hear the phenotypes? Philos Trans R Soc Lond A 2004, 359: 857-871. 10.1098/rstb.2003.1411View ArticleGoogle Scholar
  9. Griffin J, Williams H, Sang E, Clarke K, Rae C, Nicholson J: Metabolic profiling of genetic disorders: A multitissue H-1 nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem 2001, 293: 16-21. 10.1006/abio.2001.5096View ArticleGoogle Scholar
  10. Griffin J, Williams H, Sang E, Nicholson J: Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning H-1 NMR spectroscopy. Magn Reson Med 2001, 46: 249-255. 10.1002/mrm.1185View ArticleGoogle Scholar
  11. Hanahan D, Weinberg R: Hallmarks of Cancer: The Next Generation. Cell 2011, 144: 646-674. 10.1016/j.cell.2011.02.013View ArticleGoogle Scholar
  12. Hansen S, Andersen M, Birkedal H, Cornett C, Wibrand F, Oja S, Saransaari P: The important role of taurine in oxidative metabolism. Taurine 2006, 583(6):129-135.Google Scholar
  13. Heiden M, Cantley L, Thompson C: Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 2009, 324: 1029-1033. 10.1126/science.1160809View ArticleGoogle Scholar
  14. Jansen J, Shamblott M, van Zijl P, Lehtimaki K, Bulte J, Gearhart J, Hakumaki J: Stem cell profiling by nuclear magnetic resonance spectroscopy. Magn Reson Med 2006, 56: 666-670. 10.1002/mrm.20968View ArticleGoogle Scholar
  15. Kim DW, Kim KH, Yoo BC, Hong SH, Lim YC, Shin YK, Park JG: Identification of mitochondrial F(1)F(0)-ATP synthase interacting with galectin-3 in colon cancer cells. Cancer Sci 2008, 99: 1884-1891.Google Scholar
  16. Levy R, Grafi-Cohen M, Kraiem Z, Kloog Y: Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas. Mol Cancer Ther 2010, 9: 2208-2219. 10.1158/1535-7163.MCT-10-0262View ArticleGoogle Scholar
  17. Martins-Bach AB, Bloise AC, Vainzof M, Rabbani SR: Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS). Magnetic Resonance Imaging 2012, 30: 1167-1176. 10.1016/j.mri.2012.04.003View ArticleGoogle Scholar
  18. Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S: Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 2000, 85: 545-554. 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-NView ArticleGoogle Scholar
  19. Nangia-Makker P, Balan V, Raz A: Regulation of tumor progression by extracellular galectin-3. Cancer Microenviron 2008, 1: 43-51. 10.1007/s12307-008-0003-6View ArticleGoogle Scholar
  20. Newlaczyl A, Yu L: Galectin-3-A jack-of-all-trades in cancer. Cancer Lett 2011, 313: 123-128. 10.1016/j.canlet.2011.09.003View ArticleGoogle Scholar
  21. Oba-Shinjo S, Correa M, Ricca T, Molognoni F, Pinhal M, Neves I, Marie S, Sampaio L, Nader H, Chammas R, Jasiulionis M: Melanocyte transformation associated with substrate adhesion impediment. Neoplasia 2006, 8: 231-241. 10.1593/neo.05781View ArticleGoogle Scholar
  22. Romanska H, Tiziani S, Howe R, Gunther U, Guizar Z, Lalani E: Nuclear Magnetic Resonance Detects Phosphoinositide 3-Kinase/Akt-Independent Traits Common to Pluripotent Murine Embryonic Stem Cells and Their Malignant Counterparts. Neoplasia 2009, 11: 1301-1308.View ArticleGoogle Scholar
  23. Shi C, Wang X, Wu S, Zhu Y, Chung L, Mao H: HRMAS H-1-NMR measured changes of the metabolite profile as mesenchymal stem cells differentiate to targeted fat cells in vitro: implications for non-invasive monitoring of stem cell differentiation in vivo. J Tissue Eng Regen Med 2008, 2: 482-490. 10.1002/term.120View ArticleGoogle Scholar
  24. Triba M, Starzec A, Bouchemal N, Guenin E, Perret G, Le Moyec L: Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells. NMR Biomed 2010, 23: 1009-1016. 10.1002/nbm.1516View ArticleGoogle Scholar
  25. Ulrich EL, Akutsu H, Doreleijers JF, Harano YE, Ioannidis Y, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Wenger RK, Yao H, Markley JL: BioMagResBank. 2008.Google Scholar
  26. Umetrics: SIMCA-P+. 2007.Google Scholar
  27. Velho T: Metastatic melanoma – a review of current and future drugs. Drugs in Context. 2012.Google Scholar
  28. Wallace D: Mitochondria and cancer. Nat Rev Cancer 2012, 12: 685-698. 10.1038/nrc3365View ArticleGoogle Scholar
  29. Wallace D, Fan W, Procaccio V: Mitochondrial Energetics and Therapeutics. Ann Rev Pathol-Mech Dis 2010, 5: 297-348. 10.1146/annurev.pathol.4.110807.092314View ArticleGoogle Scholar
  30. Wu H, Southam A, Hines A, Viant M: High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal Biochem 2008, 372: 204-212. 10.1016/j.ab.2007.10.002View ArticleGoogle Scholar
  31. Zeng Y, Danielson KG, Albert TJ, Shapiro IM, Risbud MV: HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc. J Bone Miner Res 2007, 22: 1851-1861. 10.1359/jbmr.070620View ArticleGoogle Scholar

Copyright

© Bacchi et al.; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.